2m 2m 2m 2m 2m 2m 2m
IMMUNIC (IMUX)
NASDAQ
$16.65+$0.15 (+0.90%)
Price as of Aug 21, 2026 7:51 PM EDT- $225.1MMarket Cap
- 73.68%1-Year Change
- BiotechnologyIndustry
IMMUNIC (IMUX)
$16.65+$0.15 (+0.90%)
IMUX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $16.50 | ||
Change | +$0.40 (+2.48%) | ||
Open | $16.22 | ||
High | $16.83 | ||
Low | $16.20 | ||
Previous Close | $16.10 | ||
Volume | 147,689 | ||
30-Day Average Volume | 168,708 | ||
1-Week Change | 2.74% | ||
1-Month Change | 8.91% | ||
1-Year Change | 73.68% | ||
3-Year Change | 0.00% | ||
5-Year Change | -81.50% | ||
Fundamentals | |||
Shares Outstanding | 13.6M | ||
Total Assets | $159.2M | ||
Market Cap | $225.1M | ||
Enterprise Value | $70.0M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$34.1M | ||
Free Cash Flow | -$31.2M | ||
EBIT | -$34.1M | ||
EBITDA | -$34.1M | ||
Net Working Capital | $126.6M | ||
EPS | -$0.80 | ||
Enterprise Value/EBITDA | -2 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -21 | ||
PEG | -1 | ||
Price/Free Cash Flow | -7 | ||
Price/Operating Cash Flow | -7 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 04/27/2026 | ||
Earnings & Revenue